Value added
Next to its financial-economic expertise Gilde also has a vast knowledge of the healthcare sector. Gilde is actively involved with its portfolio companies typically by taking a board seat. It supports management in formulating and executing value-creation strategies and assists the companies in realizing their full potential. Gilde offers not only solid financial backing but also access to its extensive international network in Healthcare, highly experienced management team and operational partners.By investing in companies with clear, achievable business models, the Gilde Healthcare Funds have used its financial resources and network to create significant value for both its investors and the entrepreneurs it backs.
Wick Goodspeed, former CEO of FlowCardia, Inc.
“Gilde was the lead investor of our most significant financing round and became one of our largest and most active investors. I have found Gilde to be extremely supportive during the acquisition process by CR Bard. Their active role in strengthening and motivating management underlines their investment strategy focusing on people. It has been a pleasure to work with such a professional and experienced partner and Gilde would be the first European Healthcare investor that I would recommend to those planning for a financing round.”
Edwin Moses, CEO Ablynx
“The rapid development of Ablynx has only been possible due to the direct support and encouragement of its investors. Gilde has been an investor in Ablynx since the early days. As an investor they have a broad knowledge and network within the life sciences sector but in addition they have specific and very valuable experience in the biologicals sector. I find the Gilde style to be one in which informed advice is offered freely but never imposed upon the company. I could not think of a better investor to work with.”
Joël Jean-Mairet, former CEO GlycArt
“Working with Gilde during the last two years before GLYCART's successful exit was a great pleasure. They have a good understanding of business models that can make small companies successful. Besides cash Gilde Healthcare attracted co-investors and provided leadership and strategic guidance on our Board of Directors. If I were to start a biotech company again, I would go back to Gilde.”
Stephane Boissel, former CFO Innate Pharma
“Gilde Healthcare Partners has been a loyal partner, willing to devote significant resources to Innate Pharma. Their commitment to us with capital as well as support with their growth network has made a difference in the development of our company. Gilde has been a key investor in our company which is underlined by their significant support in our IPO.”
Bob Silverman, former CEO of mtm Laboratories AG
“Gilde was an important strategic investor into mtm, having the vision to invest at the time when the company was at a crossroad of demonstrating the significant value added component of clinical utility for its core technology and to be submitting mtm’s first PMA filing to the FDA. Gilde showed tremendous commitment to the strategic value of mtm with a second strategic investment at the right time. In addition, as a member of our board, Gilde was always supportive of Management’s vision and strategy and provided guidance and advice which was constructive to the business.”
